CAMBRIDGE, Mass.--(BUSINESS WIRE)--Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, announced today that company scientists, founders and co-founders made the following presentations at scientific conferences in the last month highlighting progress with the Company’s lead programs and the potential of its approach to developing disease modifying therapeutics:
